Edmond de Rothschild Holding’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Edmond de Rothschild Holding’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,500	Closed	-$55K	–	698
2018 Q4	$55K	Hold	1,500	–	–	﹤0.01%	514
2018 Q3	$73K	Buy	+1,500	New	+$71.1K	﹤0.01%	569
2018 Q1	–	Sell	-1,275	Closed	-$55K	–	835
2017 Q4	$55K	Hold	1,275	–	–	﹤0.01%	632
2017 Q3	$54K	Hold	1,275	–	–	﹤0.01%	645
2017 Q2	$55K	Hold	1,275	–	–	﹤0.01%	638
2017 Q1	$53K	Hold	1,275	–	–	﹤0.01%	646
2016 Q4	$50K	Buy	+1,275	New	+$51.9K	﹤0.01%	647

Other funds holding XPH

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Edmond de Rothschild Holding's XPH Position: Q1 2019 in Review

Edmond de Rothschild Holding sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2019, closing a stake of 1,500 shares — an estimated $55K sold.

Edmond de Rothschild Holding first reported a position in XPH in Q4 2016 and held it in 7 quarters. The position peaked at $73K in Q3 2018. 80 funds tracked by Wall St. Rank hold XPH as of Q1 2019.

Edmond de Rothschild Holding reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2019 after selling out during the quarter.
Edmond de Rothschild Holding sold 1,500 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2019, an estimated $55K.
Edmond de Rothschild Holding first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2016 and held it in 7 quarters.
Edmond de Rothschild Holding's State Street SPDR S&P Pharmaceuticals ETF position peaked at $73K in Q3 2018.
80 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2019.

Based on Edmond de Rothschild Holding's 13F filing for Q1 2019, filed 13 May 2019.